Viewing Study NCT07288112


Ignite Creation Date: 2025-12-26 @ 11:11 PM
Ignite Modification Date: 2026-03-08 @ 1:32 AM
Study NCT ID: NCT07288112
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-12-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Sponsor: Diakonos Oncology Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module